Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993205943> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W1993205943 endingPage "358" @default.
- W1993205943 startingPage "349" @default.
- W1993205943 abstract "Angiogenesis is an important factor for cancer development and progression in humans. Hereditary and sporadic renal cell carcinoma are characterized by inactivation of the Von-Hippel Lindau (VHL) gene, which results in hyperactivity of the hypoxia-inducible factor-a (HIFa). As a consequence, there is a production of angiogenic factors, such as vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). The activity of these factors is associated with oncogenesis, growth, and metastatic potential of renal-cell carcinoma. These data indicate that angiogenic factors are the promising therapeutic targets in this disease. Surgery can cure the patients with renal cancer if disease is diagnosed at an early stage. On the contrary, inoperable or metastatic disease is not curable. Until recently, the only drugs approved for the treatment of advanced disease were the cytokines, interferon, and interleukin. Nevertheless, only a minority of patients (about 15%) would benefited from this treatment, while the toxicity was considerable. During the last 5 years a new era of biological agents, with considerable activity has been developed and tested in clinical trials and (some of them) have been approved in USA and Europe. These agents are: Sunitinib, Bevacizumab, Sorafenib and Temserolimus. Bevacizumab is an anti-VEGF monoclonal antibody, Sunitinib and Sorafenib are multi- tyrosine kinase inhibitors (TKIs), while Temserolimus is a mTOR inhibitor. The common these in their development is the inhibition of angiogenesis, which may explain their significant activity in renal-cell carcinoma. All the agents have been proven more effective than the interferon as first or second-line treatment. This review will focus in these recent developments and the intense continuing clinical research in this field. Keywords: Renal Cell Carcinoma (RCC), Angiogenesis, Von-Hippel Lindau (VHL) gene, cytokines, interferon, Sunitinib, Bevacizumab, Sorafenib, Temserolimus" @default.
- W1993205943 created "2016-06-24" @default.
- W1993205943 creator A5017011213 @default.
- W1993205943 creator A5046961489 @default.
- W1993205943 date "2008-08-01" @default.
- W1993205943 modified "2023-09-30" @default.
- W1993205943 title "Targeting Angiogenesis in Renal Cell Carcinoma" @default.
- W1993205943 doi "https://doi.org/10.2174/156800908785133132" @default.
- W1993205943 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18690841" @default.
- W1993205943 hasPublicationYear "2008" @default.
- W1993205943 type Work @default.
- W1993205943 sameAs 1993205943 @default.
- W1993205943 citedByCount "55" @default.
- W1993205943 countsByYear W19932059432012 @default.
- W1993205943 countsByYear W19932059432013 @default.
- W1993205943 countsByYear W19932059432014 @default.
- W1993205943 countsByYear W19932059432015 @default.
- W1993205943 countsByYear W19932059432016 @default.
- W1993205943 countsByYear W19932059432017 @default.
- W1993205943 countsByYear W19932059432018 @default.
- W1993205943 countsByYear W19932059432019 @default.
- W1993205943 countsByYear W19932059432020 @default.
- W1993205943 countsByYear W19932059432021 @default.
- W1993205943 countsByYear W19932059432023 @default.
- W1993205943 crossrefType "journal-article" @default.
- W1993205943 hasAuthorship W1993205943A5017011213 @default.
- W1993205943 hasAuthorship W1993205943A5046961489 @default.
- W1993205943 hasConcept C121608353 @default.
- W1993205943 hasConcept C126322002 @default.
- W1993205943 hasConcept C143998085 @default.
- W1993205943 hasConcept C167734588 @default.
- W1993205943 hasConcept C170493617 @default.
- W1993205943 hasConcept C180361614 @default.
- W1993205943 hasConcept C2775960820 @default.
- W1993205943 hasConcept C2776248978 @default.
- W1993205943 hasConcept C2776694085 @default.
- W1993205943 hasConcept C2777025900 @default.
- W1993205943 hasConcept C2777472916 @default.
- W1993205943 hasConcept C2777802072 @default.
- W1993205943 hasConcept C2778019345 @default.
- W1993205943 hasConcept C2778695046 @default.
- W1993205943 hasConcept C2778820342 @default.
- W1993205943 hasConcept C2779490328 @default.
- W1993205943 hasConcept C2780394083 @default.
- W1993205943 hasConcept C2781068499 @default.
- W1993205943 hasConcept C502942594 @default.
- W1993205943 hasConcept C526805850 @default.
- W1993205943 hasConcept C71924100 @default.
- W1993205943 hasConceptScore W1993205943C121608353 @default.
- W1993205943 hasConceptScore W1993205943C126322002 @default.
- W1993205943 hasConceptScore W1993205943C143998085 @default.
- W1993205943 hasConceptScore W1993205943C167734588 @default.
- W1993205943 hasConceptScore W1993205943C170493617 @default.
- W1993205943 hasConceptScore W1993205943C180361614 @default.
- W1993205943 hasConceptScore W1993205943C2775960820 @default.
- W1993205943 hasConceptScore W1993205943C2776248978 @default.
- W1993205943 hasConceptScore W1993205943C2776694085 @default.
- W1993205943 hasConceptScore W1993205943C2777025900 @default.
- W1993205943 hasConceptScore W1993205943C2777472916 @default.
- W1993205943 hasConceptScore W1993205943C2777802072 @default.
- W1993205943 hasConceptScore W1993205943C2778019345 @default.
- W1993205943 hasConceptScore W1993205943C2778695046 @default.
- W1993205943 hasConceptScore W1993205943C2778820342 @default.
- W1993205943 hasConceptScore W1993205943C2779490328 @default.
- W1993205943 hasConceptScore W1993205943C2780394083 @default.
- W1993205943 hasConceptScore W1993205943C2781068499 @default.
- W1993205943 hasConceptScore W1993205943C502942594 @default.
- W1993205943 hasConceptScore W1993205943C526805850 @default.
- W1993205943 hasConceptScore W1993205943C71924100 @default.
- W1993205943 hasIssue "5" @default.
- W1993205943 hasLocation W19932059431 @default.
- W1993205943 hasLocation W19932059432 @default.
- W1993205943 hasOpenAccess W1993205943 @default.
- W1993205943 hasPrimaryLocation W19932059431 @default.
- W1993205943 hasRelatedWork W1522152077 @default.
- W1993205943 hasRelatedWork W1982699380 @default.
- W1993205943 hasRelatedWork W1993205943 @default.
- W1993205943 hasRelatedWork W2051106466 @default.
- W1993205943 hasRelatedWork W2101965356 @default.
- W1993205943 hasRelatedWork W2126958845 @default.
- W1993205943 hasRelatedWork W2159079112 @default.
- W1993205943 hasRelatedWork W2353249315 @default.
- W1993205943 hasRelatedWork W2378726502 @default.
- W1993205943 hasRelatedWork W2513463504 @default.
- W1993205943 hasVolume "8" @default.
- W1993205943 isParatext "false" @default.
- W1993205943 isRetracted "false" @default.
- W1993205943 magId "1993205943" @default.
- W1993205943 workType "article" @default.